Immunol. As of mid-March 2022, omicron is the dominant coronavirus variant in the world . . At 10.9 inches, the 4th-generation iPad Air boasts a larger screen than the iPad . Understanding of COVID-19 is evolving. 17, 261279 (2018). These modifications (indicated in Table1 and in the discussion of individual vaccines below) include two proline mutations in S2 (K986P and V987P) at the junction between two alpha helices in the pre-fusion form to avert their fusogenic conformational switch into a long alpha helix in the post-fusion form, and mutations that abolish furin cleavage between S1 and S2 to maintain the pre-fusion trimer and to prevent shedding of S118 (Fig. Google Scholar. Nelson, J. et al. Ther.Methods Clin. Nat. Voysey, M. et al. 1,2 However, coronavirus disease 2019 (COVID-19) has also demonstrated distinct clinical characteristics, such as anosmia and hypogeusia. It has been confirmed that the recent outbreak and epidemic of coronavirus disease 2019 (COVID-19) was caused by a new coronavirus that has been named SARS-CoV-2. Several of them have reached market authorization and mass production, leading to their global application on a large scale. Vaidyanathan, S. et al. Kremsner, P. et al. -Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Zhang, J. et al. The viruses are circular in shape with spikes on the surface, which appear like a halo when the virus is viewed with a microscope. Introduction of two prolines and removal of the polybasic cleavage site lead to higher efficacy of a recombinant spike-based SARS-CoV-2 vaccine in the mouse model. Nature 588, 498502 (2020). Dis. Zhang, Y. et al. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Eichinger, K. M. et al. Blood 110, 19161923 (2007). Pardi, N., Hogan, M. J. However, there may be important clues in the history and the examination that can help differentiate the two. BMJ 373, n958 (2021). Correct processing of the signal peptide by signal peptidase to generate the final N-terminus of S (Fig. J. Med. Four types cause minor illnesses like the common cold, while other coronaviruses . Sign up for the Nature Briefing newsletter what matters in science, free to your inbox daily. 384, 403416 (2021). Several lines of evidence suggest that BPL-inactivation in combination with purification processes can indeed lead to the formation of the post-fusion spike and the concomitant dissociation of S125,92. In this case, seropositivity is negligible in Europe (zero in the UK,64) and low in Africa (9% in Gambian adults,64,131). Dis. Genome Med. Specifically developed and improved ionizable lipids are used in the Moderna and Biontech-Pfizer vaccines (designated Lipid H, SM-102 and ALC-0315, respectively), which together with the molar ratios of the lipid components in LNPs play a critical role for RNA delivery54. It consists of the trimeric full-length spike that is produced as a recombinant protein in insect Sf9 (Spodoptera frugiperda) cells using a baculovirus expression system and contains mutations to stabilize S2 (K986P and V987P) as well as to delete the furin cleavage site (682-RRAS-685 changed to QQAQ)99 (Table1 and Fig. Cell 184, 39363948.e3910 (2021). It usually spreads between people who are in close contact. The team ran the headlines through a rigorous fact checking. Research Shows How To Spot Fake News About Coronavirus - Forbes Possible remedies are prime-boost regimens as already used for vaccination with the Gamaleya-Institute vaccine (Ad26 followed by Ad5) or combinations with other classes of vaccines such as mRNA vaccines. [114] Coronaviruses are a large family of viruses that can infect a range of hosts. 2d)24,25,26. Center for Virology, Medical University of Vienna, Vienna, Austria, You can also search for this author in What are the parts of a coronavirus? | Scripps Research Coronavirus - State of Michigan Irrespective of pre-existing immunity, all adenovirus vector vaccines are prone to induce immune responses against the vector particles129. 1; Black students are more likely than White students to receive harsher consequences . Lancet 396, 479488 (2020). The real reason for Ron DeSantis' Disney World district takeover Commun. NYU scientists: Largest US study of COVID-19 finds obesity the single Therefore, other adjuvants or combinations thereof with Alum have been developed for use in COVID-19 vaccines138. Both modifications are intended to avoid conversion of S into the post-fusion structure (Fig. Dis. Correspondence to ACS Central Sci. Many uncertainties remain in our understanding of the spread of Covid-19 and its management. SARS-CoV-2 - Wikipedia SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Provided by the Springer Nature SharedIt content-sharing initiative, Journal of Genetic Engineering and Biotechnology (2023), npj Vaccines (npj Vaccines) Baldo, A., Leunda, A., Willemarck, N. & Pauwels, K. Environmental risk assessment of recombinant viral vector vaccines against SARS-Cov-2. 2c)22,23,24. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Hofman, K., Shenoy, G. N., Chak, V. & Balu-Iyer, S. V. Pharmaceutical aspects and clinical evaluation of COVID-19 vaccines. According to research published in Rhinology, COVID-19 can cause a loss of taste and smell even without congestion. Details of the engineered leader sequence in the ChAdOX1-S vaccine are difficult to track, but likely comprise 32 to 34 amino acids of tPA (according to a document of the European Medicines Agency assessing thrombotic post-vaccination events, EMA/205598/2021) and may contain a P to A mutation at position 22 to improve processing by signal peptidase80. and K.S. Google Scholar. Teijaro, J. R. & Farber, D. L. COVID-19 vaccines: modes of immune activation and future challenges. Innate responses to RNA that enters cells from the outside (such as in RNA virus infections or mRNA vaccination) differ from those stimulated by adenoviruses, because RNA is sensed by other PRRs, including TLR3, TLR7 and TLR8, all located in endosomes134,135. The precise mechanisms of how the RNA is taken up by different cells after vaccination and escapes from LNPs and intracellular vesicles is incompletely resolved53,55. The structures were generated with PyMol, using protein data bank (PDB) files 7KRR and 7KRS96 for the pre-fusion forms, 6XRA for the post-fusion form25. It is part of the unknowns of current COVID-19 adenovirus vector vaccines, how the patterns of background-vector DNA and protein expression look like after vaccination and whether immune reactions to such proteins are induced. Head-to-head comparisons of mRNA vaccines will be informative to identify and evaluate differences of innate and adaptive responses as well as reactogenicity between representatives of this class of COVID-19 vaccines. Other components of cellular immunity, such as CD8 T cells, also contribute to immune responses after SARS-CoV-2 infection or vaccination, although their role in COVID-19 infections and protection from disease is still incompletely resolved12,13. Article A novel Chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. JAMA 325, 15621565 (2021). In most people, common cold symptoms usually peak within the first two to three days of infection, while the effects of Covid appear two to 14 days after exposure. Lancet https://doi.org/10.1016/s0140-6736(21)01462-8 (2021). Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. 384, 21872201 (2021). The severe consequences of the COVID-19 pandemic have created a pressing need for vaccines that not only prevent serious disease but preferentially also transmission. People become infected when they then touch their hands to their mouth, nose or eyes. Cagigi, A. Lancet 397, 18191819 (2021). 13, eabi9915. 5b), based on a previous study with Middle East respiratory syndrome coronavirus (MERS-CoV79 (Fig. Distinguishing features of Long COVID identified through immune Alharbi, N. K. et al. c Monomeric S protein of the pre-fusion spike with the RBD in red and NTD in gold, as well as the following structural details: The two stabilizing prolines (2P) are shown in pink, the FP in orange. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. Trends. Development of an inactivated vaccine candidate for SARS-CoV-2. COVID-19, short for "coronavirus disease 2019," is caused by the novel coronavirus SARS-CoV-2. Chen, N. et al. In Plotkins Vaccines 7th edn (eds Orenstein, W. A., Offit, P. A. Linares-Fernndez, S., Lacroix, C., Exposito, J.-Y. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. They use derivatives of different adenoviruses as vectors for reasons more specifically discussed in section Distinguishing features of vaccines independent of immunogen, as follows: CanSinohuman adenovirus 561, Janssen-Johnson&Johnsonhuman adenovirus 2619,62,63, Oxford-AstraZenecachimpanzee adenovirus Y2564,65,66; Gamaleya Institutehuman adenovirus 26 for the first vaccination and human adenovirus 5 for the second67,68. Information on cellular impurities are so far restricted to ChAdOx1 and comparative analyses of all adenovector vaccines are not yet available. Control. Science 369, 956 (2020). Despite incompletely resolved questions (e.g. Voss, W. N. et al. https://doi.org/10.1056/NEJMoa2108891 (2021). The authors declare no competing interests. Donors making a difference in Pakistan's flood crisis. Rev. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. 11, 909 (2020). https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018215766. The study, published in Frontiers in Public Health, finds that a distinguishing feature of COVID-19 is the order in which symptoms first appear. Vaccines 11, 695719 (2012). N. Engl. Severe acute respiratory syndrome, also known as SARS, is the other coronavirus that can cause more severe symptoms. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Adenovirus-vector and mRNA vaccines promote substantially different innate responses that will certainly influence the nature of adaptive immune responses43. Vaccine 35, 37803788 (2017). Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. COVID-19 vs. flu: Similarities and differences - Mayo Clinic a Schematic of the vaccine mRNA in BionTech-Pfizer and Moderna vaccines. The components used for LNP formulation include phospholipids, cholesterol, special cationic (ionizable) lipids and polyethylene glycol (PEGylated) lipids that are mixed in a sophisticated and critical production step (parts of which are not documented in the published literature) to yield the final vaccine53. It is therefore a major goal of all COVID-19 vaccines to present the spike and its RBD in a most native conformation for inducing a high proportion of potently neutralizing antibodies after vaccination. 8, 14301435 (2011). Recently, data from a phase 3 clinical trial became available, showing a relatively low efficacy of 47% at preventing disease (https://www.curevac.com/en/2021/06/16/curevac-provides-update-on-phase-2b-3-trial-of-first-generation-covid-19-vaccine-candidate-cvncov/), well below the efficacies reported for the BionTech-Pfizer and Moderna vaccines46,47 and below the requirement of at least 50% efficacy proposed by WHO (https://www.who.int/publications/m/item/considerations-for-the-assessment-of-covid-19-vaccines-for-listing-by-who). 11, 3618 (2020). Collectively, there are subtle differences between the two vaccines, both with respect to the RNA and the LNP carriers, and a higher amount of RNA per dose is used in the Moderna vaccine (100g) than in the BioNTech-Pfizer vaccine (30g)46,47. Cite this article. Nature 595, 344345 (2021). & Ertl, H. C. New insights on adenovirus as vaccine vectors. Also, the death rate due to coronavirus infection is fewer as well. ISSN 2059-0105 (online). Science 373, 642648 (2021). Howard County Council member 'appalled' that auditor remains in 5a) (https://patents.google.com/patent/CN111218459B/en). Vaccines (Basel) 9, 326 (2021). To reach this conclusion, the USC researchers studied the rates of symptom incidence in two . Top. Tian, J.-H. et al. Human Coronavirus Types | CDC Almuqrin, A. et al. Logunov, D. Y. et al. b Schematic of a lipidnanoparticle (LNP) used for delivery of mRNA vaccines. Lewis, D. Mix-and-match COVID vaccines: the case is growing, but questions remain. Adenovirus 5 is used in the CanSino vaccine and the second dose of Gamaleya vaccines (section Adenovirus-vector vaccines and Table1). Expert Rev. The domains were colored according to reference.20. This classification was based on the following: Detection of cases attributed to Omicron in multiple countries, including among those without travel history. A plethora of viral mutants arose and spread since the emergence of SARS-CoV-2104,105. CrossRef Google Scholar 4 Baker, MA, Sands, KE, Huang, SS, et al. Daedalean: the AI copilot looking for permission to fly Thank you for visiting nature.com. Front. Excessive innate responses can not only result in strong reactogenicity of vaccination but also restrict antigen translation from the vaccine RNA, thus impairing adaptive immune responses. These are the products (in alphabetical order) of CanSino Biological Inc./Beijing Institute of Biotechnology, Janssen-Johnson&Johnson, Oxford-AstraZeneca and The Gamaleya Institute Moscow (Table1). Coronavirus - Wikipedia mRNA, adenoviral vector as well as inactivated whole-virus vaccines are now in widespread use, and a subunit vaccine is in a final stage of authorization. Sometimes a common cold can inhibit your sense of smell or taste, but this is due to mucus build-up and congestion. 88) could not be found in the literature. & Nauwynck, H. J. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Cleared for takeoff. LithiumBank Resources distinguishing itself with industry-leading It is believed (but not systematically studied and formally shown) that muscle cells, fibroblasts, endothelial cells, and/or immune cells such as dendritic cells contribute to the expression of S after intramuscular vaccination40,41,42. Curr. The viral RNA is sneaky: its features cause the protein synthesis . These vaccines are now used worldwide for mass immunization programs, and data on vaccine efficacies justify the hope that vaccination can indeed be the main instrument for preventing serious disease and death, and more generally for combating the pandemic1,2,3,4. While on site, please take precautions to protect yourself and others from Covid-19 by wearing a mask and maintaining social distance as outlined in the Center for Disease Control (CDC) Guidelines. 1, 131138 (2021). Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. 5G mmWave: Facts and fictions you should definitely - Android Authority Anyone you share the following link with will be able to read this content: Sorry, a shareable link is not currently available for this article. Li, Y. et al. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans, Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic, SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates, COVID-19 vaccines: where we stand and challenges ahead, Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants, Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines, ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants, A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19, Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19, https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines, https://github.com/NAalytics/Assemblies-of-putative-SARS-CoV2-spike-encoding-mRNA-sequences-for-vaccines-BNT-162b2-and-mRNA-1273/blob/main/Assemblies%20of%20putative%20SARS-CoV2-spike-encoding%20mRNA%20sequences%20for%20vaccines%20BNT-162b2%20and%20mRNA-1273.docx.pdf, https://www.curevac.com/en/2021/06/16/curevac-provides-update-on-phase-2b-3-trial-of-first-generation-covid-19-vaccine-candidate-cvncov/, https://www.who.int/publications/m/item/considerations-for-the-assessment-of-covid-19-vaccines-for-listing-by-who, https://patents.google.com/patent/CN111218459B/en, https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/, https://www.biorxiv.org/content/10.1101/2021.04.20.440647v2, https://doi.org/10.1038/s41591-021-01413-7, https://www.medrxiv.org/content/10.1101/2020.11.09.20228551v1, https://www.researchsquare.com/article/rs-558954/v1, https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018215766, https://doi.org/10.1016/s0140-6736(21)01462-8, https://doi.org/10.1038/s41586-021-03777-9, https://www.medrxiv.org/content/10.1101/2021.05.07.21256809v1, https://www.researchsquare.com/article/rs-440461/v1, https://doi.org/10.1080/08820139.2021.1904977, https://www.biorxiv.org/content/10.1101/2021.04.14.439844v1, http://creativecommons.org/licenses/by/4.0/, Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model, Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19, COVID-19 vaccines adverse events: potential molecular mechanisms, Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine, SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study, COVID-19 two years on: development and implementation of vaccines against SARS-CoV-2. The two protease cleavage sites are indicated by arrows. During exocytosis, virus particles encounter the protease furin in the trans-Golgi network (TGN), which cleaves the S protein into its membrane-associated S2 subunit and the distal S1 subunit at a characteristic polybasic cleavage site16. Verbeke, R., Lentacker, I., De Smedt, S. C. & Dewitte, H. The dawn of mRNA vaccines: The COVID-19 case. Natl Acad. 384, 18851898 (2021). b Schematic of the process using an additional N-terminal leader sequence (signal peptide and propeptide of tPA), as used in the vaccine of Oxford-Astra Zeneca, based on reference. The Differences Between COVID-19 and the Common Cold - Verywell Family Mol. Key features of the vaccines discussed in this review are summarized in Table1. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. . Towards understanding ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Both of these technologies have already been applied successfully to the production of vaccines against other viral diseases84. Lancet 397, 23312333 (2021). The results from a hydrogeological study at LithiumBank Resources Corp (TSX-V:LBNK)'s 100%-owned Park Place lithium brine project, located in Alberta are "surprisingly favorable," according to analysts at Noble Capital.. 178, 104792104792 (2020). Currently, a slightly but significantly increased risk of thrombotic events (including cerebral venous sinus thrombosis) was reported after vaccination with Oxford-AstraZeneca and Janssen adenovirus vector vaccines and has raised considerable concern74,75. Published information about the production process is available for two inactivated whole-virus vaccines manufactured by the Chinese companies Sinopharm and Sinovac (Table1). "As a council member, I'm disappointed and appalled that no one else would think that there was anything wrong with this report," said Jones, a Democrat who represents District 2. PubMed Pinto, D. et al. Experts know the new coronavirus is not a bioweapon. They disagree on Trends Biochem. There is an urgent need to clarify the pathogenic mechanism underlying the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In parallel to genetic vaccines, more conventional approaches of vaccine development were pursued with similar intensity and led to the authorization of inactivated whole-virus vaccines and a subunit vaccine that is in a stage of pre-authorization (Table1). Lancet 397, 99111 (2021). Nat. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens. The effect of dissociation of soluble S1 from the trimer complex on the quality of immune responses is incompletely understood, but some data suggest it may contribute to a higher proportion of non-neutralizing relative to neutralizing antibodies19,81. With this kind of vaccines, the specific design of genetic sequences for the correct formation and presentation of properly folded spike proteins to B cells are in the foreground of interest. & Lor, K. Immune responses induced by mRNA vaccination in mice, monkeys and humans. Barnes, C. O. et al. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action, https://doi.org/10.1038/s41541-021-00369-6. Coronavirus - BBC News ACS Central Sci. Rev. Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. Front. C. R. Biol. Prefusion RSV F immunization elicits Th2-mediated lung pathology in mice when formulated with a Th2 (but not a Th1/Th2-balanced) adjuvant despite complete viral protection. However, we would like to emphasize that there is an enormous pipeline of further developments (https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines), including subunit vaccines that contain only parts of the S protein, in some instances combined with components of other viral proteins. Ther.Nucleic Acids 12, 530542 (2018). Mild or Moderate Covid-19 | NEJM Science 372, 1108 (2021). Article In some cases, however, COVID-19 can lead to respiratory failure, lasting lung and heart muscle damage, nervous system problems, kidney failure or death. Another mRNA vaccine, manufactured by the company CureVac (current name CVnCoV; Table1) is in an advanced stage of development56. https://doi.org/10.1038/s41541-021-00369-6, DOI: https://doi.org/10.1038/s41541-021-00369-6. CAS In the CanSino vaccine, the signal peptide of S is replaced by that of human tPA (https://patents.google.com/patent/CN111218459B/en). 3,4 Although the . Viruses 13, 54 (2021). IUBMB Life 69, 297304 (2017). The first category consists of mRNA and adenoviral vector vaccines (herein referred to as genetic vaccines, sections: Genetic vaccinesgeneral, mRNA vaccines, Adenovirus-vector vaccines), both of which do not contain the spike protein but provide genetic information for its biosynthesis in body cells of the vaccinee. Piccoli, L. et al. A case report of Covid-19 in an autoimmune pulmonary alveolar The research team ran two studies, enlisting 1700 adults. Bos, R. et al. Liang, Z. et al. Frontiers | Features of Cytokine Storm Identified by Distinguishing Google Scholar. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention (CDC), during a meeting with President Biden and members of the White House Covid-19 Response Team on the Omicron . 5a) may be especially critical for obtaining natively folded S, because there is a cysteine immediately downstream of the cleavage site (amino acid 2) that has to form an S-S bond with the cysteine at position 136. Science 372, 525 (2021). Duan, L. et al. Proteolytic cleavage into S1 and S2 occurs in the TGN similar to that in infected cells, but some shedding of cleaved S1 and conversion of S2 into its post-fusion structure (S2*) may occur in the absence of stabilizing mutations. Hopefully, more details will become available in the near future. PubMedGoogle Scholar. Nature 584, 443449 (2020). PubMed Central Hodgson, S. H. et al. 5b). 7, eabe5575 (2021). Nature https://doi.org/10.1038/s41586-021-03777-9 (2021). BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Some people infected with the coronavirus have mild COVID-19 illness, and others have no symptoms at all. These subunits remain associated in the trimer through noncovalent interactions, and the virus is probably secreted via exocytic lysosomes with disrupted lysosomal functions17. Coronavirus Rumor Control | FEMA.gov Jagannathan, P. & Wang, T. T. Immunity after SARS-CoV-2 infections. Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine. J. Med. Delrue, I., Verzele, D., Madder, A. The variant gambit: COVID-19s next move. Brun, J. et al. CAS J. Med. Encapsulating the RNA genome is the viral envelope (teal . Neutralizing activity was also observed for antibodies against S2, but the potency was lower than of those against S127. RNA vaccines contain fully functional mRNAs that can be translated directly into the S protein, whereas additional biosynthetic steps are required with adenovirus vector vaccines, including intranuclear transcription of the vector DNA into RNA and processing to generate functional mRNAs. proteins that help give the virus its structure and enable it to replicate. Wang, H. et al. Front. RSV vs. COVID-19 Coronavirus: Symptoms and Their Differences - WebMD Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor. Tumban, E. Lead SARS-CoV-2 candidate vaccines: expectations from phase III Trials and recommendations post-vaccine approval. Wiener Klinische Wochenschrift 133, 271283 (2021). Distinguishing features of current COVID-19 vaccines: knowns and We also address the grey matter of additional variables, such as ill-defined downstream production processes and purity of vaccines as well as differences in triggering sensors of innate immunity. This enormous progress was achieved with fundamentally different vaccine technologies used in parallel. Indeed, substantially reduced neutralization titers against some VOCs were observed with sera after immunization with mRNA and adenovirus vector vaccines106,107,108,109, pointing to the importance of the problem. J. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. . Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Nature 590, 630634 (2021). Vaccine 39, 865867 (2021). We have reviewed the most apparent and significant differences among the vaccines as far as they can be recognized from published literature, which unfortunately is still incomplete. Coronavirus Disease (COVID-19): Symptoms, Causes & Prevention